Society's failure to protect a precious resource: Antibiotics

The Lancet

Volumn 378, Issue 9788, 2011, Pages 369-371

  Carlet, Jean ^a   Collignon, Peter ^b   Goldmann, Don ^c,d   Goossens, Herman ^e   Gyssens, Inge C ^f,g   Harbarth, Stephan ^h   Jarlier, Vincent ⁱ   Levy, Stuart B ^j   N'Doye, Babacar ^k   Pittet, Didier ^h   Richtmann, Rosana ^l   Seto, Wing H ^m   Van Der Meer, Jos Wm ^f   Voss, Andreas ^g  

^a WHO   (France)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c INSTITUTE FOR HEALTHCARE IMPROVEMENT   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HASSELT UNIVERSITY   (Belgium)

^h UNIVERSITY OF GENEVA   (Switzerland)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Programme National de Lutte Contre les Infections Nosocomiales (PRONALIN)   (Senegal)

^l Emilio Ribas Infectious Diseases Institute   (Brazil)

^m HOSPITAL AUTHORITY   (Hong Kong)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COLISTIN; DAPTOMYCIN; NEW DELHI METALLOBETALACTAMASE 1; OXAZOLIDINONE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ATTITUDE TO HEALTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CLINICAL EFFECTIVENESS; COMMUNICABLE DISEASE; DRUG TREATMENT FAILURE; EDITORIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAND; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HYGIENE; INFECTION CONTROL; INFECTION RISK; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PANDEMIC; PATHOGENESIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACODYNAMICS; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SALMONELLA; SOCIAL ASPECT; SOCIAL ATTITUDE; SOCIETY;

EID: 79960743378     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60401-7     Document Type: Note

References (26)

1. CM Kunin, T Tupasi, WA Craig Use of antibiotics: a brief exposition of the problem and some tentative solutions Ann Intern Med 79 1973 555 560
2. H Goossens, R Ferech, R Van der Stichele, M Elseviers Outpatient antibiotic use in Europe and association with resistance: a cross national database study Lancet 365 2005 579 587 (Pubitemid 40247914)
3. European Centre for Disease Prevention and Control EARS-Net Database http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/Database.aspx (accessed March 4, 2011).
4. K Kennedy, P Collignon Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers Eur J Clin Microbiol Infect Dis 29 2010 1501 1506
5. K Grave, J Torren-Edo, D Mackay Comparison of the sales of veterinary antibacterial agents between 10 European countries J Antimicrob Chemother 65 2010 2037 2040
6. H Boucher, LG Miller, RR Razonable Serious infections caused by methicillin-resistant Staphylococcus aureus Clin Infect Dis 51 2010 S183 S197
7. SJ van Hal, DL Paterson, IB Gosbell Emergence of daptomycin resistance following vanvomycin-unresponsive Staphylococcus aureus bacteremia in a daptomycin-naïve patient-a review of the literature Eur J Clin Microbiol Infect Dis 2010 10.1007/s10096-010-1128-3 Published online Dec 30.
8. PD Johnson, SA Ballard, EA Grabsch et al. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to the emergence of van B E faecium sequence type 203 J Infect Dis 202 2010 1278 1286
9. SA Chisholm, JW Mouton, DA Lewis et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink J Antimicrob Chemother 65 2010 2141 2148
10. B Uma, K Prabhakar, S Rajendran et al. Prevalence of extended spectrum beta lactamases in Salmonella species isolated from patients with acute gastroenteritis Indian J Gastroenterol 29 2010 201 204
11. M Ofner-Agostini, A Simor, M Mulvey et al. Risk factors for and outcomes associated with clinical isolates of Escherichia coli and Klebsiella species resistant to extended-spectrum cephalosporins among patients admitted to Canadian hospitals Can J Infect Dis Med Microbiol 20 2009 43 48
12. SH Koo, KC Kwon, HH Cho, JY Sung Genetic basis of multi-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea Korean J Lab Med 30 2010 498 506
13. KK Kumarasamy, MA Toleman, TR Walsh et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study Lancet Infect Dis 10 2010 597 602
14. J Li, Y Ma, C Hu et al. Dissemination of cefotaxime-M producing Escherichia coli isolates in poultry farms, but not in swine farms, in China Foodborne Pathog Dis 7 2010 1387 1392
15. P Collignon, JH Powers, TM Chiller, A Aidara-Kane, FM Aarestrup World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals Clin Infect Dis 49 2009 132 141
16. M Jajoo, V Kumar, M Jain, S Kumari, V Manchanda Intravenous colistin administration in neonates Pediatr Infect Dis J 30 2011 218 221
17. Infectious Diseases Society of America Bad bugs, no drugs http://www.idsociety.org/workarea/showcontent.aspx?id=5554 (accessed March 4, 2011).
18. United States Centers for Disease Prevention and Control Get Smart programme http://www.cdc.gov/getsmart (accessed Dec 4, 2010).
19. Council of the European Union Council Recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC) Official Journal of the European Communities L34 45 2002 13 16
20. European Centre for Disease Prevention and Control and European Medicines Agency ECDC/EMEA Joint Technical Report. The bacterial challenge: time to react http://ecdc.europa.eu:en:publications/forms/ECDCdispForm.aspx?ID=444 (accessed March 4, 2011).
21. B Huttner, H Goossens, TJ Verheij, S Harbarth Characteristics and outcomes of public health campaigns with the aim to improve outpatient antibiotic use in high income countries Lancet Infect Dis 10 2010 17 31
22. S Earnshaw, DL Monnet, B Duncan et al. European antibiotic awareness day 2008: the first Europe-wide public information campaign on prudent antibiotic use; methods and survey activities in participating countries Eurosurveillance 14 2010 23 30
23. JM Hughes Preserving the lifesaving power of antimicrobial agents JAMA 305 2011 1027 1028
24. TH Dellit, RC Owens, JE McGowan et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 2007 159 177 (Pubitemid 46084814)
25. WH Seto, F Otaiza, CL Pessoa-Silva World Health Organization infection prevention and control network Core comp onents for infection prevention and control programs: a World Health Organization networks report Infect Control Hosp Epidemiol 31 2010 948 951
26. ME Hulscher, RP Grol, JW van der Meer Antibiotic prescribing in hospitals: a social and behavioural scientific approach Lancet Infect Dis 10 2010 167 175